Thursday , May 26 2022

Johnson and Johnson launch the public-private partnership of Singapore in unexpected research



[ad_1]

Johnson & Johnson Vision gave a collaboration of $ 26.35 million with the Eye Eye Research institute, the research center of the Singapore National Eye Center, focusing on the treatment of disorders, non-eye impairment worldwide.

With myopia being predicted to affect half the world's population by 2050, or more than 5 billion people, J & J described an unexpected vision as the greatest threat to eye health in this century. One billion people are expected to have a severe form of myopia, which can ultimately increase the risks of retina and blindness.

The three-year public-private partnership will study how the condition develops and could be treated-with the aim of developing predictive equipment to identify those at risk of high myopia. It will also investigate therapies and possible methods to prevent start-up and sequence.

Your Daily Newsletter – Free

Enjoy this story? Subscribe to FierceBiotech!

Biopharma is a fast growing world with great ideas coming everyday. Our subscribers rely on FierceBiotech as their source of reading for the latest news, analyzes and data in biotechnology and pharma research and development. To read on, register today for biotechnology news and updates that are provided correctly to your inbox!

"The incidence of myopia increases at a scary rate around the world and if it can not be analyzed, human and financial tolls could be rooted in the next decades, especially in Asia," said chief officer scientific J & J, Paul Stoffels, MD in statement.

RELATED: J & J pays $ 4B + for Abbott Medical Optics

If left unverified, myopia can lead to deterioration and retiniol separation, cataracts and glaucoma, due to the extension of the eyeball. J & J anticipates that it can be the main cause of loss and blindness irrecoverable vision.

"Documented progress in myopia, especially among young people, is a serious concern and if we can understand the basic mechanisms that contribute to its rapid progress, we can work to tackle the" a problem on its roots, "said teacher Aung Tin, executive director of SERI. For the co-operation, J & J contributes an investment of $ 15.78 million, while SERI investment equates to $ 10.57 million.

East Asia and Singapore are expected to see the greatest impact, with prevalence among young people reaching between 80% and 97%, with concentrations in urban areas. In Singapore, 75% of teenagers depend on glasses – while myopia rates increase from 10% to 80% among children in China between 6 and 18 years of age.

[ad_2]
Source link